Skip to main content
Frontiers in Psychiatry logoLink to Frontiers in Psychiatry
. 2024 Feb 16;15:1372373. doi: 10.3389/fpsyt.2024.1372373

Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings

Terence H W Ching 1,*, Lucia Amoroso 1, Calvin Bohner 1, Elizabeth D'Amico 1, Jeffrey Eilbott 1, Tara Entezar 1, Madison Fitzpatrick 1, Geena Fram 1, Rachael Grazioplene 1, Jamila Hokanson 1, Anastasia Jankovsky 1, Stephen A Kichuk 1, Bradford Martins 1, Prerana Patel 1, Henry Schaer 1, Sarah Shnayder 1, Chelsea Witherow 1, Christopher Pittenger 1,2,3,4, Benjamin Kelmendi 1
PMCID: PMC10905264  PMID: 38435972

Error in Author List

In the published article, there was an error in the author list, and Anastasia Jankovsky was erroneously excluded. The corrected author list appears below.

Terence H. W. Ching,1 Lucia Amoroso,1 Calvin Bohner,1 Elizabeth D'Amico,1 Jeffrey Eilbott,1 Tara Entezar,1 Madison Fitzpatrick,1 Geena Fram,1 Rachael Grazioplene,1 Jamila Hokanson,1 Anastasia Jankovsky,1 Stephen A. Kichuk,1 Bradford Martins,1 Prerana Patel,1 Henry Schaer,1 Sarah Shnayder,1 Chelsea Witherow,1 Christopher Pittenger,1-4 Benjamin Kelmendi1

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Psychiatry are provided here courtesy of Frontiers Media SA

RESOURCES